PRO-DEX, INC.

PDEX ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $77.5M $66.6M $53.8M $46.1M $42.0M $38.0M $34.8M $27.2M
Cost of Revenue $53.2M $47.1M $39.3M $33.3M $28.9M $24.5M $21.7M $17.4M
Gross Profit $24.3M $19.5M $14.6M $12.7M $13.1M $13.6M $13.1M $9.8M
Gross Margin 31.4% 29.3% 27.0% 27.7% 31.2% 35.7% 37.7% 36.0%
Operating Expenses
Research & Development $3.3M $3.6M $3.2M $2.8M $3.0M $4.4M $2.3M $1.9M
SG&A Expense $8.0M $5.2M $4.1M $4.0M $4.9M $4.1M $3.2M $2.5M
Operating Income $13.0M $10.7M $7.2M $5.8M $5.1M $4.5M $7.1M $5.0M
Operating Margin 16.8% 16.1% 13.3% 12.5% 12.2% 11.9% 20.3% 18.4%
Interest Expense $533.0K $464.0K $352.0K $236.0K $220.0K
Pretax Income $18.0M $12.1M $2.6M $9.4M $5.7M $7.6M $7.9M $5.4M
Income Tax Expense $4.4M $3.1M $507.0K $2.4M $1.1M $1.4M $1.8M $1.3M
Net Income $13.7M $9.0M $2.1M $7.1M $4.6M $6.2M $6.1M $4.1M
Net Margin 17.6% 13.5% 4.0% 15.3% 10.9% 16.2% 17.5% 15.3%
EPS (Basic) $4.24 $2.73 $0.61 $1.98 $1.26 $1.63 $1.56 $0.99
EPS (Diluted) $4.12 $2.67 $0.60 $1.95 $1.21 $1.57 $1.50 $0.97
Shares Outstanding (Basic) 3.2M 3.3M 3.5M 3.6M 3.6M 3.8M 3.9M 4.2M
Shares Outstanding (Diluted) 3.3M 3.4M 3.6M 3.6M 3.8M 3.9M 4.1M 4.3M
Dividends Per Share
← Newer Page 1 of 2 Older →